References
Alshamsi F, Alshammari K, Belley-Cote E, Dionne J, Albrahim T, Albudoor B, Ismail M, Al-Judaibi B, Baw B, Subramanian RM, Steadman R, Galusca D, Huang DT, Nanchal R, Al Quraini M, Yuan Y, Alhazzani W, Group G (2019) Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. Intensive Care Med. https://doi.org/10.1007/s00134-019-05783-y
Banayosy AE, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R (2004) First use of the molecular adsorbent recirculating system technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J 50(4):332–337. https://doi.org/10.1097/01.mat.0000131251.88146.cd
O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R (1988) Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94(5):1186–1192. https://doi.org/10.1016/0016-5085(88)90011-x
Zhou YD, Han QF, Tang QB, Cheng YL, Shi JX (2017) Clinical effect of combined artificial extracorporeal liver support therapy for toxic hepatic failure. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 35:51–53. https://doi.org/10.3760/cma.j.issn.1001-9391.2017.01.013
Qin G, Shao J-G, Wang B, Shen Y, Zheng J, Liu X-J, Zhang Y-Y, Liu Y-M, Qin Y, Wang L-J (2014) Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure. Medicine 93(28):e338. https://doi.org/10.1097/md.0000000000000338
Thompson J, Jones N, Al-Khafaji A, Malik S, Reich D, Munoz S, MacNicholas R, Hassanein T, Teperman L, Stein L, Duarte-Rojo A, Malik R, Adhami T, Asrani S, Shah N, Gaglio P, Duddempudi A, Borg B, Jalan R, Brown R, Patton H, Satoskar R, Rossi S, Parikh A, ElSharkawy A, Mantry P, Sher L, Wolf D, Hart M, Landis C, Wigg A, Habib S, McCaughan G, Colquhoun S, Henry A, Bedard P, Landeen L, Millis M, Ashley R, Frank W, Henry A, Stange J, Subramanian R (2018) Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial. Liver Transpl 24(3):380–393. https://doi.org/10.1002/lt.24986
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no competing interest.
Ethical approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xu, X., Qin, B. Extracorporeal liver support in patients with liver failure. Intensive Care Med 46, 829–830 (2020). https://doi.org/10.1007/s00134-020-05928-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-020-05928-4